The United Kingdom’s Medicines and Healthcare Products Regulatory Agency strengthened its warnings on GLP-1 receptor agonists and dual GLP-1/GIP agonists to include…
Source link : https://www.medpagetoday.com/endocrinology/obesity/119660
Author :
Publish date : 2026-01-30 14:42:00
Copyright for syndicated content belongs to the linked Source.